Screener
Veracyte VCYT Biopharmaceutical and other revenue — Compensation expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Veracyte in its filing.
Tagged under the XBRL concept vcyt:CostOfRevenueCompensationExpense.
The source filing: Veracyte’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 8:07 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001384101-26-000031
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Cost of testing revenue: | ||
| Laboratory supplies and reagents expense | 12,314 | 13,067 |
| Sample collection expense | 3,288 | 2,825 |
| Compensation expense | 9,804 | 5,611 |
| Other cost of testing revenue (1) | 4,937 | 3,385 |
| Allocation of facilities and IT expenses | 2,963 | 3,372 |
| Total cost of testing revenue | 33,306 | 28,260 |
| Cost of product revenue: |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Veracyte's biopharmaceutical and other revenue — compensation expense?
- Veracyte (VCYT) reported biopharmaceutical and other revenue — compensation expense of $0 in Q1 2026.
- How has Veracyte's biopharmaceutical and other revenue — compensation expense changed year-over-year?
- Veracyte's biopharmaceutical and other revenue — compensation expense decreased by 100.0% year-over-year, from $1.24M to $0.
- What is the long-term trend for Veracyte's biopharmaceutical and other revenue — compensation expense?
- Over 3 years (2022 to 2025), Veracyte's biopharmaceutical and other revenue — compensation expense has grown at a -28.1% compound annual growth rate (CAGR), from $8.94M to $3.32M.
- What does biopharmaceutical and other revenue — compensation expense mean?
- This metric tracks the total personnel-related costs, including salaries, benefits, and stock-based compensation, specifically allocated to the biopharmaceutical and research services segment. It highlights the human capital investment required to maintain and scale the company's collaborative service offerings.
Ask your AI about Veracyte's biopharmaceutical and other revenue — compensation expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude